[HTML][HTML] Atrial giant cell myocarditis with preserved left ventricular function: a case report and literature review
Y Tang, L Qi, L Xu, L Lin, J Cai, W Shen, Y Liu… - Journal of Cardiothoracic …, 2023 - Springer
Giant cell myocarditis (GCM) is a rare and fatal inflammatory disorder induced by T-
lymphocytes, typically affecting young adults. Generally, this disease presents with a rapidly …
lymphocytes, typically affecting young adults. Generally, this disease presents with a rapidly …
[HTML][HTML] The Synergistic Relationship Between Atrial Fibrillation and Diabetes Mellitus: Implications for Cardiovascular and Metabolic Health
M Mohsin, H Zeyad, H Khalid, A Gapizov, R Bibi… - Cureus, 2023 - ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) and atrial fibrillation (AF) are widespread chronic
conditions that profoundly impact public health. While the intricate mechanisms linking these …
conditions that profoundly impact public health. While the intricate mechanisms linking these …
[HTML][HTML] A Combination of Ex Vivo and In Vivo Strategies for Evaluating How Much New Oral Anticoagulants Exacerbate Experimental Intracerebral Bleeding
JRP Ferreira, ID Sucupira, GMC Carvalho, FF Paiva… - TH Open, 2023 - thieme-connect.com
Background Intracerebral hemorrhage is the most serious complication of anticoagulant
therapy but the effects of different types of oral anticoagulants on the expansion of these …
therapy but the effects of different types of oral anticoagulants on the expansion of these …
Apply Anticoagulants after Discharge not Benefit to the Incidence of Symptomatic Thrombus in High‐Altitude Areas: A Retrospective Study
X Dang, Z Liu, X Sheng, Y Liu - Orthopaedic Surgery, 2023 - Wiley Online Library
Objective Many guidelines indicate that continuous use of anticoagulant drugs reduces the
incidence of venous thrombus (VT), but no studies show the effect on the incidence of …
incidence of venous thrombus (VT), but no studies show the effect on the incidence of …
[HTML][HTML] Factor Xa inhibitors versus warfarin in patients with non-valvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis of randomized …
MM Zahoor, S Mazhar, A Azhar, FM Khan… - Annals of Medicine …, 2024 - journals.lww.com
Background: Patients with non-valvular atrial fibrillation with diabetes face increased stroke
and cardiovascular risks. This study compares factor Xa inhibitors and warfarin using data …
and cardiovascular risks. This study compares factor Xa inhibitors and warfarin using data …